Ó³»­´«Ã½

Tests that look for hundreds of tumor mutations in blood samples could one day be used to detect residual disease in patients after treatment.

After living with angiosarcoma for decades, Jim Chapdelaine found support in an online community of patients and contributed to research that’s now shedding light on the roots of his own illness

Largest study yet of angiosarcoma reveals new mutations and suggests therapeutic possibilities for some subtypes

Pan-Cancer Project brings researchers closer to identifying all major cancer-causing genetic mutations.

Using a single-needle biopsy and new technology for tumor diagnosis, researchers provide a more detailed window into cancer biology, tumor type, and mechanisms of therapy response and resistance

A study testing thousands of medicines in hundreds of cancer cell lines in the lab uncovers new tricks for many old drugs

Study will help narrow down the list of targets for the next generation of cancer treatments

A computational model could improve the selection of tumor antigens for personalized cancer vaccines that are now in early-stage clinical trials.

The finding suggests a potentially more targeted way to treat certain patients with the disorder, called CHIP, which commonly affects the elderly

The new tool more accurately distinguishes mutations that drive cancer from ones that don’t, and could help focus future research and drug development.